Processa PharmaceuticalsPCSA
13F holders, Q2 2025 (June 30)13holders +4
6new positions
2sold out
$0.20avg. 13F price*
At the end of Q2 2025, 13 institutions reported holding Processa Pharmaceuticals Inc. (PCSA) in their 13F filings, up 4 from Q1 2025. 6 opened new positions and 2 sold out. The largest holders were Virtu Financial LLC ($21K), UBS Group AG ($13K) and Alpine Global Management, LLC ($11K).
- Company
- Processa Pharmaceuticals Inc.
- CUSIP
- 74275C304
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $26K |
| Exits | 2 | $24K |
All 13F filers, Q1 2025 → Q2 2025: 267,829 shares bought and 66,005 shares sold, net +201,824 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Virtu Financial LLC | 0.00% | Add +142.3% | 104,723 | $21K |
| UBS Group AG | 0.00% | Add +115278.6% | 64,612 | $13K |
| Alpine Global Management, LLC | 0.00% | New | 53,416 | $11K |
| Geode Capital Management, LLC | 0.00% | Add +47.0% | 50,573 | $10K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 41,848 | $9K |
| Vanguard Group Inc. | 0.00% | No change | 24,433 | $5K |
| Jane Street Group, LLC | 0.00% | New | 19,270 | $4K |
| Sequoia Financial Advisors, LLC | 0.00% | New | 11,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.2% | 2,462 | $505 |
| Wells Fargo & Company | 0.00% | No change | 154 | $32 |
| Bank of America Corp. | 0.00% | Add +191.9% | 108 | $22 |
| SBI Securities Co., Ltd. | 0.00% | New | 12 | $2 |
| Osaic Holdings, Inc. | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is PCSA's weight in each manager's 13F, not the share of Processa Pharmaceuticals Inc. the manager owns.